138 related articles for article (PubMed ID: 35705112)
1. The emerging role of NF2 alterations in new and established subtypes of renal cell carcinoma.
Paintal A; Antic T
Hum Pathol; 2023 Mar; 133():87-91. PubMed ID: 35705112
[TBL] [Abstract][Full Text] [Related]
2. NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: A Comprehensive Study of 14 Cases.
Paintal A; Tjota MY; Wang P; Fitzpatrick C; Wanjari P; Stadler WM; Gallan AJ; Segal J; Antic T
Am J Surg Pathol; 2022 May; 46(5):617-627. PubMed ID: 35034039
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of biphasic renal cell carcinomas with hyalinized stroma and psammoma bodies associated and not associated with NF2 alteration.
Chumbalkar V; Wang P; Paner GP
Hum Pathol; 2022 Mar; 121():11-18. PubMed ID: 34929230
[TBL] [Abstract][Full Text] [Related]
4. Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma.
Collins K; Hwang M; Antic T; Paintal A; Argani P; Matoso A; Gopinath A; Baskovich B; Mehra R; Williamson SR; Idrees MT; Barletta JA; Anderson WJ; Hirsch MS; Hornick JL; Acosta AM
Histopathology; 2022 Nov; 81(5):577-586. PubMed ID: 35971742
[TBL] [Abstract][Full Text] [Related]
5. Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: Another Provisional Entity Emerging From the Papillary Renal Cell Carcinoma Pandora's Box.
Gopinath A; Mubeen A; Jamal M; Mohammed I; Gopireddy DR; Baskovich B
Int J Surg Pathol; 2021 Oct; 29(7):783-787. PubMed ID: 33729031
[TBL] [Abstract][Full Text] [Related]
6. Renal cell tumor with sex-cord/gonadoblastoma-like features: analysis of 6 cases.
Wang G; Amin MB; Grossmann P; Ptáková N; Hayes M; Hartmann A; Agaimy A; Lopez JI; Michal M; Hes O
Virchows Arch; 2022 Feb; 480(2):349-358. PubMed ID: 34775513
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: further support for the newly proposed entity.
Wang XT; Xia QY; Fang R; Zhang RS; Ye SB; Li R; Wang X; Lu ZF; Ma HH; Zhou XJ; He HY; Zhao M; Rao Q
Hum Pathol; 2022 May; 123():102-112. PubMed ID: 35192800
[TBL] [Abstract][Full Text] [Related]
8. Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC): A Distinctive Neoplasm Associated With Somatic NF2 Mutations.
Argani P; Reuter VE; Eble JN; Vlatkovic L; Yaskiv O; Swanson D; Dickson BC; Antonescu CR; Matoso A; Gagan J; Palsgrove DN
Am J Surg Pathol; 2020 Jul; 44(7):901-916. PubMed ID: 32217839
[TBL] [Abstract][Full Text] [Related]
9. Kidney Tumors: New and Emerging Kidney Tumor Entities.
Siadat F; Mansoor M; Hes O; Trpkov K
Clin Lab Med; 2023 Jun; 43(2):275-298. PubMed ID: 37169446
[TBL] [Abstract][Full Text] [Related]
10. Kidney Tumors: New and Emerging Kidney Tumor Entities.
Siadat F; Mansoor M; Hes O; Trpkov K
Surg Pathol Clin; 2022 Dec; 15(4):713-728. PubMed ID: 36344185
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy.
Hacking SM; Pavlick D; Wang Y; Carneiro BA; Mullally M; Lu S; Canepa M; Bratslavsky G; Jacob J; Necchi A; Spiess PE; Wang L; Yakirevich E; Ross J
Oncologist; 2023 Jul; 28(7):e508-e519. PubMed ID: 36917021
[TBL] [Abstract][Full Text] [Related]
12. Recurrent CYP2A6 gene mutation in biphasic hyalinizing psammomatous renal cell carcinoma: Additional support of three cases.
Ding X; Zhang W; Yu W; Li Y; Shao G; Zhang L; Zhao RC; Li X
Pathol Res Pract; 2023 May; 245():154468. PubMed ID: 37104959
[TBL] [Abstract][Full Text] [Related]
13. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup.
Liu YJ; Houldsworth J; Emmadi R; Dyer L; Wolff DJ
Cancer Genet; 2020 Jun; 244():40-54. PubMed ID: 32434132
[TBL] [Abstract][Full Text] [Related]
14. Papillary renal cell carcinoma: current and controversial issues.
Angori S; Lobo J; Moch H
Curr Opin Urol; 2022 Jul; 32(4):344-351. PubMed ID: 35674688
[TBL] [Abstract][Full Text] [Related]
15. TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype.
Hakimi AA; Tickoo SK; Jacobsen A; Sarungbam J; Sfakianos JP; Sato Y; Morikawa T; Kume H; Fukayama M; Homma Y; Chen YB; Sankin A; Mano R; Coleman JA; Russo P; Ogawa S; Sander C; Hsieh JJ; Reuter VE
Mod Pathol; 2015 Jun; 28(6):845-853. PubMed ID: 25676555
[TBL] [Abstract][Full Text] [Related]
16. Somatic Mutations of TSC2 or MTOR Characterize a Morphologically Distinct Subset of Sporadic Renal Cell Carcinoma With Eosinophilic and Vacuolated Cytoplasm.
Chen YB; Mirsadraei L; Jayakumaran G; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE
Am J Surg Pathol; 2019 Jan; 43(1):121-131. PubMed ID: 30303819
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH
Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388
[TBL] [Abstract][Full Text] [Related]
18. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
19. The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth.
Lobo J; Ohashi R; Helmchen BM; Rupp NJ; Rüschoff JH; Moch H
Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680535
[TBL] [Abstract][Full Text] [Related]
20. YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.
White SM; Avantaggiati ML; Nemazanyy I; Di Poto C; Yang Y; Pende M; Gibney GT; Ressom HW; Field J; Atkins MB; Yi C
Dev Cell; 2019 May; 49(3):425-443.e9. PubMed ID: 31063758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
